ROVI cuts 2026 revenue guidance on lower pharma demand
Investing.com Gold reports: ROVI cuts 2026 revenue guidance on lower pharma demand. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: ROVI cuts 2026 revenue guidance on lower pharma demand. Full body text was unavailable at ingest time, so this brief is based on headline context.